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Very little is known about the mechanisms responsi-
ble for the findings that binding of nuclear receptors
(NR) to some promoter elements leads to transcriptional
activation, whereas binding to others leads to repres-
sion. Case in point is the group of epidermal keratin
genes and their DNA sequences responsible for repres-
sion by NR. Keratin response elements (KREs) interact
with receptors for retinoic acid, thyroid hormone, and
glucocorticoids. KREs, by their structure and sequence,
direct the binding of retinoic acid and thyroid hormone
as homodimers and glucocorticoids as monomers. Such
specific DNA-receptor interactions are crucial for the
repression signal of transcription. In this paper we have
analyzed the interactions between the KREs and NR
that lead to such repression. We have found that KREs
are promoter-independent. They not only provide a
docking platform for the receptors, but also play a key
role in directing the receptors to bind into particular
configurations and coordinating the interactions among
different receptors. Both an intact KRE and an intact
receptor DNA-binding domain are necessary for the reg-
ulation to occur, which emphasizes the importance of
interaction between the DNA and NR for proper signal-
ing. Furthermore, KREs allow simultaneous binding of
multiple receptors, thus providing fine-tuning of tran-
scriptional regulation. The DNA/DNA-binding domain
interactions in keratin promoters exemplify tissue and
gene specificity of hormone action.
Glucocorticoids (GC)1 and retinoic acid (RA) are important
regulators of development, differentiation, and gene expression
in many tissues, including epidermis (1–3). They are exten-
sively used in the treatment of many skin diseases ranging
from psoriasis to skin cancers (4). GC, similar to thyroid hor-
mone and retinoids, mediate their effect through nuclear re-
ceptors (NR) that regulate the transcription of specific genes.
NR constitute a large family of transcription factors that act by
binding to specific sequences, response elements (RE), in the
regulated genes (5). Once bound to the DNA, the receptors
interact with co-regulators and the transcriptional machinery
to regulate transcription (6, 7).
Extensive studies over the years have shown that steroid
receptors act as homodimers whereas nonsteroid receptors,
such as T3R and RAR, act as heterodimers in regulating tran-
scription (8–10). These studies led to the current dogma that
heterodimers of T3R and RAR with RXR are the functional
protein complexes involved in gene regulation. Indeed, very few
exceptions to this rule have been found. The complex TRE in
the TSH gene contains a palindrome that activates and an
independent half-site that mediates binding of a monomer of
T3R and repression of transcription (11, 12). Similarly the TRE
in thyrotropin-releasing hormone and apolipoprotein A1 genes
contains a complex element that involves the T3R monomer
and a T3R-RXR heterodimer (13, 14). Furthermore, formation
of a monomer  homodimer of GR was found to inhibit tran-
scription of the POMC gene (15). It has been shown recently
that the sequence of a given RE and the context of the promoter
region in which the RE is located play important roles in GR
regulation and interactions with AP1 transcription factors (16).
Keratin response elements (KREs), which we have identified in
a family of epidermal keratin genes, also constitute exceptions
to the dimerization rules. KREs mediate repression of K5, K14,
K6, K16, and K17 keratin genes by binding of homodimers of
RAR and T3R in addition to monomers of GR (17, 18).
The KREs comprise the first group of native negative regu-
latory elements identified in a gene family (19). KREs have a
similar structure, with clusters of sites providing a number of
possible combinations for binding of NR. Additionally, we have
identified the “signature” sequences in the acidic keratin and
basic keratin gene families (19). Signature sequences are
highly conserved clusters (over 90% identical) of binding sites
found within the acidic keratin and basic keratin gene group.
Interestingly, they are found only in the group of keratin genes
that are regulated by all three receptors: RAR, T3R, and GR,
but not in the keratin or other epidermal genes that are regu-
lated only by RAR or GR (19).2
In this paper we analyze the molecular function of such
specific, complex response elements that mediate repression of
transcription in a selected group of genes. We found that KREs
are promoter independent. We also found that KREs, by posi-
tioning a receptor in a particular configuration, form a signal
for repression. This does not arise from blocking or displacing
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an activator. Both an intact KRE and a receptor’s DBD are
necessary for repression. Furthermore, KREs allow simultane-
ous binding of at least two receptors (T3R and GR), and T3R
dominates over GR in transcriptional regulation. Therefore,
the role of KREs is to instruct the receptors to bind in a specific
configuration and to create a relative order of binding among
the receptors. This means that in addition to interacting with
NRs in a very specific manner, KREs introduce a new level of
transcriptional regulation allowing simultaneous interplay of
multiple receptors.
EXPERIMENTAL PROCEDURES
Plasmids, Their Growth and Purification—Plasmids pK14CAT,
pK5CAT, pK14TREmut, pK14EREmut, pKRE-TK, and pRSVZ have
been described previously (19, 20). Briefly, pK14CAT and pK5CAT
contain the 2 kilobases of a 5 upstream regulatory region of the K14
and 2.5 kilobases of the 5 upstream regulatory region of the K5 gene.
pK14TREmut was created by introducing 3-base pair mutations into
the KRE of the K14 promoter thus converting the core of the KRE into
the consensus TRE (Fig. 1 and Ref. 21). Similarly, using the same
method (21) pK14EREmut was created to contain the perfect ERE in
the core of the KRE (Fig. 1). Plasmids containing human GR nuclear
receptor, RAR/ER chimeric receptor, GRE-CAT, and ERE-CAT were
gifts from Dr. P. Chambon (22, 23), plasmids containing DR-4, T3R-
GAL4, RAR-GAL4, and VP116 were gifts from Dr. H.H. Samuels (24).
GRE-CAT, ERE-CAT, DR-4, and VP16 plasmids contain consensus
response elements for glucocorticoid (GRE), estrogen (ERE), thyroid/
retinoid receptor (TRE), or GAL-4, respectively, and are used as estab-
lished positive controls in co-transfection experiments. RAR/ER chi-
meric receptor is a retinoic acid receptor containing the DNA-binding
domain (DBD) of the estrogen receptor (ER). Plasmids were grown in
JM101 Escherichia coli host to saturation density in LB medium. DNA
was extracted and purified using the Magic Mega Prep Kit from
Promega.
Cloning and Mutagenesis—We have used a previously described
method (25) to change the KRE site into the GAL-4-binding site in the
K5 promoter and create K5GAL-4. Primers used for polymerase chain
reactions were: K5GAL4F, 5-GGGCTCGAGCGGAGTACTGTCCTC-
CGCCCAGGCATGCCCA; K5GAL4R, 5-TTTCTCGAGCACAGTGGT-
GTGGGGTGCAA; K5outF, 5-GGGTCTAGAGGATCCCCGGGTTC-
CTAAC; K5outR, 5- GGGAAGCTTCTTGTTCCTGGTGGAG. We used
XhoI for the inside restriction enzyme and the insert was introduced
into XbaI and HindIII restriction sites. Using this method we have
created plasmid K5GAL-4, which instead of the KRE contains a gal-4-
binding site in the same position (Fig. 1).
Cell Growth—HeLa cells were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% calf serum at 37 °C in a 5%
CO2 atmosphere in media containing penicillin and streptomycin as
described (26). The day before transfection cells were plated onto
60-mm dishes in low density (10–15% confluency). Four hours before
transfection the medium was changed to phenol red-free Dulbecco’s
modified Eagle’s medium supplemented with charcoal pretreated, de-
pleted 10% calf serum, as described (26).
Normal human foreskin epidermal keratinocytes were a generous
gift from Dr. M. Simon. The cultures were initiated using 3T3 feeder
layers as described (27) and then frozen in liquid N2 until used. Once
thawed, the keratinocytes were grown without feeder cells in defined
serum-free keratinocyte medium supplemented with epidermal growth
factor and bovine pituitary extract (keratinocyte-SFM, Life Technolo-
gies, Inc.). Cells were expanded through two 1:4 passages before trans-
fection and transfected at 100% confluency.
Transfection using Ca3(PO4)2 and BES Co-precipitation—We have
generally followed published procedures for cells that were at 15–20%
confluence (28). At the time of transfection, to each dish were added 3–5
g of the CAT plasmid, 1 g of the nuclear receptor expression vector
plasmid, 1 g of pRSVZ reference plasmid, and a sufficient amount of
carrier to bring the total to 10 g of DNA. The DNA mixture was
prepared with 50 l of 2.5 M CaCl2 and filled to 500 l of dH2O and
subsequently added to 500 l of BES buffer followed by vigorous shak-
ing. After 10 min incubation at room temperature the precipitate mix-
ture was aliquoted to the duplicate plates. After transfection, cells were
incubated in Dulbecco’s modified Eagle’s medium supplemented with
10% charcoal-pretreated depleted calf serum in the presence or absence
of 0.1 or 1 M dexamethasone (Sigma) in ethanol or T3 (Sigma) in 0.1 N
NaOH. The cells were harvested 48 h after transfection by scraping into
5 ml of phosphate-buffered saline, washed once more in phosphate-
buffered saline, and resuspended in 150 l of 0.25 M Tris buffer, pH 7.8.
All transfections were performed on duplicate plates, and each trans-
fection experiment was repeated two to five times. CAT and -galacto-
sidase assay were performed as described (29).
Transfection by Polybrene with Me2SO Shock—Transfections using
Polybrene with Me2SO shock were used to transfect the DNA into the
100% confluent keratinocytes as previously described (29). On the day
of transfection, cells were washed and incubated in the basal medium
without epidermal growth factor and bovine pituitary extract. Each
transfection contained 10–15 g/dish of keratin-CAT construct and 3
g/dish of RSVZ construct. The cells were then incubated with or
without 0.1 or 1 M dexamethasone (Sigma) dissolved in ethanol or T3
(Sigma) in 0.1 N NaOH. 48 h after transfection cells were washed twice
with phosphate-buffered saline and harvested by scraping. The cell
disruption by repeated freeze-thaw cycles, as well as CAT and -galac-
tosidase assays have also been described (29).
Enzyme Assays—Briefly, the substrate solution contained 6 mg of
o-nitrophenyl-D-galactoside (Sigma) freshly dissolved in PM buffer (66
mM Na2HPO4, 33 mM NaH2PO4, 40 mM mercaptoethanol, 2 mM MgSO4,
and 0.1 mM MnCl2). The reaction mixture contained 100 l of substrate
solution, 300 l of PM buffer, and 50 l of keratinocyte cell extract or
20–30 l of HeLa cell extract. It was incubated at 37 °C until develop-
ment of yellow color was obvious, usually 10–30 min. The time of the
reaction was recorded and the reaction stopped by addition of 0.4 ml of
1 M Na2CO3. OD420 was measured on a spectrophotometer (Gilford).
The CAT reaction mixture contained 69 l of 1 M Tris HCl, pH 7.8, 1
l of 14[C]chloramphenicol (Cm, 40–50 mCi/mmol, PerkinElmer Life
Science), 20 l of 4 mM acetyl-CoA solution, 30–60 l of cell extract, and
enough water to bring the total reaction volume to 150 l. After incu-
bation at 37 °C for 30 min, the mixture was extracted into 1 ml of ethyl
acetate, phases were separated by brief centrifugation, the organic
layer was transferred to a new tube, and the solvent evaporated. The
residue was dissolved in 30 l of ethyl acetate and separated by thin
layer chromatography on silica gel in chloroform:methanol, 95:5. The
plates were exposed to x-ray film for 12 to 24 h, and the intensity of
radioactive spots determined using Ambis Radioanalytic System (Am-
bis, Inc., San Diego, CA). The conversion of chloramphenicol to its
monoacetylated derivative was kept below 50% by varying the amount
of extract or the duration of the reaction.
All CAT values were normalized for transfection efficiency by calcu-
lating the ratio of CAT activity to -galactosidase in each transfected
plate. Each transfection experiment was separately performed three or
more times, with each data point resulting from duplicate or triplicate
transfections.
Electrophoretic Gel Mobility Shift Assays and Footprinting—The E.
coli-expressed DNA-binding domain portion of hGR was a gift from
Dr. H. H. Samuels and previously described (30). Purification of recom-
binant cT3Ra was done following a previously published procedure (17,
18). Oligonucleotides were synthesized on a Pharmacia Gene Assembler
Plus Synthesizer.
1 g of primer K14ft (5-AGGGGGCGGGCCTGGCACTTTCCA) was
labeled by polynucleotide kinase (Promega) and [-32P]dATP (Amer-
FIG. 1. Plasmids used in the experiments. The corresponding
sequences of the KRE and introduced changes (bold lowercase letters)
are shown on the left. Arrows are marking the position and orientation
of the half-sites. Plasmid diagrams are shown on the right. Black box
represents the KRE (note that the size is not proportional to the pro-
moter size). Striped box represents the GAL-4-binding site. White lines
represent single base pair substitutions.
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sham Pharmacia Biotech). 1.5  106 cpm of each primer is used in the
primer extension reaction using K14ft template (5-GACCTGGCTGG-
GAGTTGGCGCTAGCCTGTGGGTGATGAAAGCCAAGGGGAATGGA-
AAGTGCCAGGCCCGCCCCCT) and Klenow endonuclease (Roche
Molecular Biochemicals). The product was purified from the 2.5% aga-
rose gel. The band corresponding to the size of the probe is cut out of the
gel and eluted overnight in TE buffer, pH 8, at 4 °C, which was
followed by ethanol precipitation. Double-stranded TRE oligonucleotide
AGGTCATGACCT, flanked by HindIII overhangs (5-AGCTT-3) was
labeled with [-32P]dATP, using the Klenow fragment of E. coli DNA
polymerase I. 30,000 cpm of each resulting probe was mixed with 2.5
fmol of purified receptor proteins and incubated first for 30 min at room
temperature then for 10 min at 4 °C. The incubation was done in a
30-l volume in 25 mM Tris, pH 7.8, 500 M EDTA, 88 mM KCl, 10 mM
2-mercaptoethanol, 0.1 g of aprotinin, 0.1 g of poly(dI-dC), 0.05%
Triton X-100 (v/v), 10% glycerol (v/v). Samples were either loaded on 4%
polyacrylamide gels and separated by electrophoresis (20–25 mA) at
4 °C for 2 h with a buffer containing 10 mM Tris, 7.5 mM acetic acid,
and 40 M EDTA, pH 7.8, or used in DNase I footprinting experiments
(see below). Gels were dried and exposed to x-ray film for 4 h at 70 °C.
For the DNase I footprinting experiments we have followed previ-
ously described protocol (18). Two different reactions were performed in
parallel: A/G Maxam-Gilbert sequencing (following the standard proto-
col) and DNase I footprinting. For the footprinting reaction our protocol
for gel shifts was used to allow binding of the protein to the DNA (see
above). After 20 min incubation at4 °C, 50 l of solution containing 10
mM MgCl2 and 5 mM CaCl2 was added and incubated 1 min on ice. Next,
3 l of the 1:25 dilution of the DNase I (5 units/ml stock), which we have
found optimal for our conditions, was added and incubated exactly 1
min on ice. The reaction was stopped by adding 90 l of “stop” solution
containing 20 mM EDTA, pH 8.0, 1% SDS, 0.2 M NaCl, and 100 g/ml
yeast RNA. DNA was purified by phenol extraction, followed by ethanol
precipitation. The pellet was resuspended in 1.4 l of 9 M urea, 1%
Nonidet P-40 and, after mixing, 4.6 l of formamide loading buffer
(commercial from U. S. Biochemical Corp.) was added. All samples were
heated at 90 °C for 5 min, chilled on ice, and loaded on the 12%
sequencing polyacrylamide gel together with samples with A/G Maxam-
Gilbert sequencing reactions of the same DNA. Gels were dried on the
gel-dryer and exposed to x-ray film. The footprint localization was
determined by the bands that are “protected” by the bound protein from
cleavage by DNase I, which appears on the film as “disappeared” bands
when the footprinted sample lane on the gel is compared with the
sample that had no protein in the mixture. The protected bands are
then compared with the A/G sequence lane on the same gel, revealing
the nucleotides involved in binding of protein.
RESULTS
The KREs Mediate Transcriptional Regulation by Active Re-
pression—The complex structure of KREs provides binding for
all three receptors, RAR, T3R, and GR. To establish the binding
patterns of these receptors to the KRE we performed footprint-
ing experiments with K14RE and purified T3R, RAR, and
GR-DBD. We found that the binding sites for each of these
three receptors overlap (Fig. 2). RAR occupies the largest por-
tion of the KRE, from 50 to 92. The T3R site is significantly
smaller, occupying 16 base pairs, from 62 to 78. Last, the
primary GR-binding site is located at 51 to 57. As we
increased the concentration of GR we found that up to four GR
monomers bind to the KRE (19).
The immediate question is what is the function of the KREs?
There are three possible models: 1) docking, where KREs only
provide a binding sites for the receptors, while the negative
regulation occurs through interactions with additional auxil-
iary repressor protein(s); 2) de-activation, where the receptor
displaces a positive regulator(s) from keratin DNA, or forms
inactive complexes with the positive regulators that convert
activation to inhibition; and 3) active repression, where KREs,
by their structure and sequence, instruct the receptor to act as
a negative regulator. This last model implies that the informa-
tion for negative regulation is inherent in the sequence of
KREs, and that this information is conveyed to the receptor
through specific DNA-protein interactions, causing the recep-
tor to repress transcription.
First, we tested the docking hypothesis by converting the
K5RE into a GAL4-binding site. This mutagenesis introduced a
17-nucleotide long binding site, which completely altered the
sequence and structure of the KRE but still providing a docking
site to the receptor through the GAL4-binding site. If the KRE
only functions to provide a docking site for the receptor, the
GAL4-binding site would also provide this function, allowing
the receptor to bind and repress transcription. If, however, the
binding of the receptor is not the only function of the KRE,
repression should not occur.
We tested the K5GAL4 mutant in co-transfection experi-
ments with the GAL4-RAR and GAL4-T3R in primary human
keratinocytes. Both GAL4-RAR and GAL4-T3R induced rather
than repressed the K5-GAL4 promoter in the presence of their
respective ligands (Fig. 3A), whereas the wild-type K5 pro-
moter was not regulated by GAL4 constructs. The control plas-
mid containing the GAL-4-binding site, VP116, was induced by
both GAL4 receptors, as expected. We obtained similar results
from co-transfections in HeLa cells (data not shown). This
result clearly eliminates the simple docking hypothesis. It fur-
ther suggests that the basic function of the receptor simply
docked to a promoter is to induce transcription.
To test the deactivation hypothesis, we altered K14RE into
the consensus TRE palindrome. The resulting mutant pro-
moter had only three nucleotides changed, while the orienta-
tion and spacing between the half-sites remained intact. It is
important to note that the introduced mutations are substitu-
tions, not insertions or deletions, therefore they altered neither
the size nor the position of the RE. If the deactivation model is
correct, the mutation would still allow the receptor to bind and
perform its function of blocking a positive regulator. Therefore,
the mutated promoter should be normally repressed by the
receptors. However, if the function of the KRE is not simply
de-activation, the mutated keratin promoter should not be re-
pressed by the receptors. This is exactly what we found. First,
we wanted to establish the binding properties of the K14TRE
mutant. We used the consensus TRE, K14RE, and K14TRE
FIG. 2. Footprinting of the purified T3R-, GR-DBD-, and RAR-
binding sites on the KRE. The DNA surface occupied by T3R is
marked with the gray rectangle; GR-DBD with black, and RAR with
white. Numbers indicate the position of the KRE relative to ATG.
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mutant DNA as probes in gel-shift experiments. The consensus
TRE palindrome used as a control probe binds RAR, as mon-
omer and homodimer. A similar binding pattern was found
with K14RE. Interestingly, we found that the K14TRE mutant
binds RAR with an affinity even higher than the wild-type
K14RE (Fig. 3C). The introduced mutations did allow the effi-
cient binding of the receptor and therefore the receptor should
block the binding of a positive regulator, if de-activation was
the mechanism. However, RAR did not regulate the
K14TREmut in the presence of its ligand (Fig. 3B), which
indicates that the deactivation model does not hold. Please note
that RAR and its ligand, as expected, induced the DR-4, a
positive control containing a consensus positive TRE cloned
into the TK promoter. This means that the de-activation is not
the function of the NR bound to KREs.
An alternative explanation could be that the introduced mu-
tations changed the binding of a positive regulator. If a positive
regulator is not able to bind the mutant, a decrease in basic
promoter activity should be detected. On the other hand, if the
introduced mutations increased the binding of the positive
regulator so that RAR can no longer block its binding, the
basic promoter activity should be increased. However, there
was no significant difference in the basic level of transcription
between the WT and the mutated promoter (data not shown).
This argues against the existence of a displaceable positive
regulator, strengthening our conclusion that the function of the
KREs is not de-activation.
This leaves us with the third hypothesis that KREs are true
negative elements that mediate active repression through di-
rect binding of the receptors. To test this hypothesis we have
removed the KRE from its promoter and cloned it into a het-
erologous promoter. The TK-promoter has been used exten-
sively to test heterologues DNA binding elements (31, 32). If
the active repression model is correct, the KRE should still
function as a negative RE even in the context of the TK pro-
moter. This is precisely what we found: the KRE cloned into the
TK promoter mediated repression by RAR and T3R (Fig. 3D)
and GR (18). This means that KREs are “self-contained nega-
tive REs,” i.e. they contain all the information necessary to
instruct the receptor to repress transcription, independently of
the background of the promoter. This result is very important
because it proves that KREs are not promoter-context depend-
ent and that they mediate regulation of keratin gene expres-
sion by active repression.
The DNA-binding Domain of the NR “Reads” the Instruction
from the KRE Sequence—Binding of the receptor to the KREs
mediates repression of transcription. This means that KREs
instruct the receptor to repress through specific interactions
with the receptor DBD. To test this instructive model, we
altered the DBD of the RAR to eliminate the specific interac-
tions between the RAR DBD and the KRE. We used a chimeric
RAR that has the DBD of the ER. ER does not regulate keratin
gene expression, i.e. its DBD has no ability to communicate
with KREs. If our hypothesis is correct, the chimeric ER/RAR
should not regulate the keratin promoter. Indeed, while ER/
RAR normally regulates the ERE-CAT positive control, the
FIG. 3. KREs are true negative response elements. A, docking of the receptors to the promoter using GAL4 is not sufficient for repression
to occur. Results from co-transfection experiments in primary human keratinocytes with K5WT and K5GAL4 mutant promoter are presented. The
change in K5 promoter is shown in the diagram and in Fig. 1. B, de-activation is not the model of receptor function on KREs. In co-transfection
experiments K14-WT, containing intact KRE, is repressed whereas K14TREmut, containing mutated KRE, which is converted to the consensus
TRE, is not regulated by RAR in the presence of its ligand. Control plasmid, DR-4 (consensus TRE), contains two direct repeats of half-sites
(AGGTCA), spaced by four nucleotides, and it is induced by RAR, as expected. C, K14TREmut efficiently binds the receptor although it does not
mediate repression of the K14 promoter. In gel-shift experiments, purified RAR receptor binds similarly to all three probes, the TRE consensus
palindrome (a positive control), K14RE, and K14TREmut. The intensity of the bands corresponds to the affinity of the binding. D, KREs are not
promoter context-dependent. KRE was cloned into the minimal TK promoter and tested for regulation in co-transfection experiments. KRE-TK was
repressed by both RAR and T3R in the presence of their ligands. This means that KRE confers repression to heterologous, TK promoter. TRE-TK
(a positive control that contains consensus TRE) was induced by both receptors whereas TK (negative control that contains no response elements)
was not regulated, as expected.
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chimera does not regulate the K5 and K14 promoters (Fig. 4).
This means that an intact DBD of the RAR receptor is neces-
sary for communication with the KRE and repression of keratin
gene expression.
Conversely, we modified the K14RE into a consensus ERE. If
the KRE plays a role in instructing the receptor, this mutant
promoter should instruct the ER/RAR chimera to induce,
rather than repress transcription. Results from co-transfection
experiments confirm this hypothesis. The ER/RAR chimera, in
a ligand-dependent manner, induced the K14EREmut (Fig. 4).
In other words, if RAR is bound to KRE via RAR-DBD it
represses, but if it is bound to ERE via ER-DBD it induces. This
means that specific interactions between the intact DBD and
KRE are necessary “key players” in the mechanism of repres-
sion of keratin gene expression.
KREs Mediate Nuclear Receptor “Cross-talk”—To determine
how the simultaneous presence of multiple receptors modu-
lates the binding pattern to KREs and regulation of keratin
gene expression, we have performed footprinting, gel-shift, and
co-transfection experiments with a combination of T3R and GR.
We found that T3R and GR can simultaneously bind the KRE
in gel-shift and footprinting experiments (Fig. 5). T3R occupies
its two binding sites, which overlap the middle two of the four
binding sites for GR. Interestingly, the binding of the T3R does
not interfere with the binding of the GR to the outlying two
binding sites. The binding of the T3R is “supershifted” by the
presence of the GR, and the supershift “grows” due to the
increased amount of the GR (Fig. 5A). These results were
confirmed in footprinting experiments. Small amounts of GR
present simultaneously with T3R allow the binding of the T3R
to its sites and of the GR to its primary binding site. As the
concentration of GR increases, the quaternary GR-binding site,
which was unoccupied, binds to another monomer of the GR.
This means that the middle two binding sites can be occupied
by T3R and the outer two sites by two monomers of GR.
Furthermore, the T3R and GR interact when they are simul-
taneously bound to the KREs. In co-transfection experiments,
T3R blocks keratin gene regulation by dexamethasone when
both are present at the same time (Fig. 5B). Conversely, dex-
amethasone does not affect the induction of keratin gene ex-
pression mediated by unliganded T3R. We conclude that T3R
dominates over GR in regulating keratin gene transcription.
We have shown previously that RAR dominates over T3R in
regulating keratin genes (17). These findings are important
because they illustrate how the complex REs mediate multiple,
simultaneous regulatory signals (Fig. 5C).
DISCUSSION
In this study we show that the molecular function of the
complex response elements in keratin genes (KREs) is to de-
termine a specific configuration of the bound receptors and
cause them to repress transcription. This means that the KREs
create the message of repression by instructing the receptors
how to bind. In addition, KREs, by providing simultaneous
binding and interaction of multiple receptors create a hierarchy
among the receptors, a new level of transcriptional regulation.
KREs serve as an excellent example of sequences customized to
select for specific receptor configuration, and to allow simulta-
neous receptor binding to provide a gradient of hormone action.
We found that the KREs function independently of the pro-
moter context and that sequence of the KREs and receptors
DBD are necessary for the regulation to occur.
The concept of DNA as a regulator of transcriptional signal is
not novel (for review, see Refs. 33–35). For example, studies by
Lefstin and Yamamoto included a variety of positive GREs and
suggested that REs may act as “ligands for regulators” (34).
Similarly, we found that in the case of KREs, DNA creates a
signal to shut down the transcription of its own promoter, i.e.
the DNA acts as an “antagonist” for the receptor. However,
KREs do even more than that. They allow the interplay of
multiple nuclear receptors, thus creating a gradient of hormo-
nal action. The sequences of KREs, supplying the signal for
repression, allow three receptors with their respective ligands
to respond to a large variety of physiological conditions under
which the repression of keratin genes is required. This is ex-
tremely important in the epidermis because it is a target tissue
that is exposed to and depends on complex hormonal regula-
tion. The purpose of the receptor interplay is to provide the
fine-tuning of transcriptional regulation of keratin genes in a
large variety of physiological and pathological conditions.
The hierarchy in receptor regulation of keratin genes is the
following: RAR dominates over T3R (17) and T3R dominates
over GR, although both receptors can simultaneously bind to
the KRE. The footprinting results with these receptors on KRE
suggest such a hierarchy. The RAR footprint is the largest,
dominating the space and occupying almost the entire KRE,
whereas the T3R, although overlapping, occupies a much
smaller segment. Furthermore, GR binds as four monomer
FIG. 4. Intact KRE and the receptor’s DBD are necessary for repression of keratin gene expression. A, K14WT is not regulated by
ER/RAR chimera receptor in co-transfection experiments because there is no communication between ER-DBD and KRE. Conversely, changing the
KRE to ERE restores the communication and the K14EREmut is regulated. Schematic presentations of the receptors used in the experiments are
shown on the top followed by the diagrams of the plasmids, shown below. Results from co-transfection experiments are shown at the bottom. B,
cartoon illustrates the conclusion that intact KRE and receptor’s DBD are necessary for the repression.
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units and all four must be bound for regulation to occur. There-
fore, one can envision multiple regulatory levels that are being
introduced. The first is the concentration of the hormones that
reach and are produced in epidermis (36, 37). For example, if
there is a high concentration of RA in the epidermis, the dif-
ferentiation process is inhibited and keratinocytes become “ba-
sal-like” by changing their phenotype and keratin gene expres-
sion pattern (1). Furthermore, the simultaneous presence of
two hormones multiply the possibilities of regulatory patterns.
For example, if RA and T3 are present, RAR will dominate over
the T3R in regulating keratin genes (17). The presence of T3
will allow GC regulation whereas its absence will block it.
Furthermore, the type and amount of the hormones become
irrelevant if there are no receptors. Therefore, the next regu-
latory level is the presence and a relative amount of a partic-
ular receptor. Keratinocytes express multiple NRs, such as
RAR, RXR, T3R, GR, ER, progesterone receptor, peroxisome
proliferator-activated receptor, and farnesoid X receptor etc. (1,
38–42). In the case of the presence of multiple receptors, their
relative amounts become an important factor. Combined, the
type and amount of receptors with the type and the amount of
respective hormones determine the next regulatory level:
which co-regulators will interact and participate in transcrip-
tional regulation. For example, if the GC are present in high
amounts GR binds KRE as four monomers. In this context,
none of the common co-regulators (SRC-1, GRIP-1, and NCoA)
are involved due to a specific conformation of the GR (18).
Furthermore, when the liganded RAR or T3R interact with
KRE, NCoA/SRC-1 become co-repressors rather than
co-activators.3
Obviously, there is a large variety of possible scenarios, all
examples of fine-tuning necessary for maintenance of the tar-
get tissue, epidermis. It is no longer “only” the DNA-receptor
and its ligand co-regulators integrators and transcriptional
machinery. The complex elements, such as KREs, provide nu-
merous combinations of possible interactions among three re-
ceptors independently and simultaneously, their ligands and
their interactive proteins. The important point is that such
complicated, fine-tuning is made possible by very specific DNA
elements, e.g. the chaos is well organized by the KREs. By
providing the binding of a specific configuration of the receptors
and multiple receptor binding, KREs introduce a new dimen-
sion in the transcriptional regulatory systems. Although these
DNA elements are uniquely present in the keratin gene family,
we believe that as we focus our studies more on native hormone
elements in their physiological contexts, simultaneous multiple
transcriptional signals maintained by specific DNA elements
will probably become a general phenomenon.
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